![]() |
市場調査レポート
商品コード
661003
糖鎖生物学の世界市場:製品タイプ、アプリケーション、エンドユーザー、地理別の成長率、動向および予測Glycobiology Market - Growth, Trends, and Forecast (2020 - 2025) |
糖鎖生物学の世界市場:製品タイプ、アプリケーション、エンドユーザー、地理別の成長率、動向および予測 |
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
|
糖鎖生物学は、2018年から2023年の予測期間中に、約13%のCAGRで成長すると見込まれています。糖鎖生物学は、生命科学の重要な分野であり、細菌生理学の研究、新規薬物の開発およびプロテオミクス研究において多様な役割を果たす糖鎖の研究を含んでいます。研究者は、糖鎖応用のために、質量分析、MALDI-TOFなどの様々な技術を活用しています。したがって、質量分析計およびMALDI-TOF質量分析計を含む糖鎖生物学機器の需要は、近い将来に増加すると予想されます。
当レポートでは、世界の糖鎖生物学市場を調査し、全体的な市場動向、製品・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。
The glycobiology market will show rapid growth due to the increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies.
Drug Discovery and Development is Expected to be the Largest Growing Segment
On the basis of application, drug discovery and development has been accounted for the largest market share. This is primarily owing to extensive R&D and increased government funding for research related to glycomics and proteomics. There is an increasing R&D investments by pharmaceutical companies, which increases the drug discovery and development of glycomics. For instance, R&D expenditure of Merck accounted for USD 9.8 billion, in 2018.
The other applications segment is anticipated to witness the high CAGR due to rising clinical trials and R&D expenses incurred by key companies for research.
North America is Found Leading the Glycobiology Market
North America has been accounted for the largest market share due to the presence of key pharmaceutical and biopharmaceutical companies. The presence of well-established healthcare infrastructure and accessibility to advanced products have driven the regional market. Moreover, there is also increasing applications of glycans in various cancers and increasing funds from the government in enhancing the field of glycobioogy, that helps the market to grow over the forecast period.
There has been a presence of a considerable number of companies that are significantly contributing to the market growth. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.
Biotechnology Companies